Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets

Motokuni Aoki(Osaka City University), Toshio Ogihara(Osaka University), Ryuichi Morishita(The University of Osaka), Iwao Kida(The University of Osaka), Y Kaneda(The University of Osaka), Takashi Nakamura(Tohoku University), A Moriguchi(The University of Osaka), Yoshiaki Taniyama(The University of Osaka), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Kunio Matsumoto(Kanazawa University)
Gene Therapy
February 24, 2000
10.1038/sj.gt.3301104
Cited by 244

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588